AHK-Cu and Ipamorelin Interaction

Synergistic
Mechanism-based 47% confidence

AHK-Cu and Ipamorelin have a synergistic interaction with 47% confidence. AHK-Cu and Ipamorelin work through complementary pathways. Growth hormone signaling supports tissue repair processes. A well-established combination in recovery protocols. These compounds primarily affect different organ systems.

Compound Profiles

AHK-Cu

Hair Growth Copper Peptide | Dermal Papilla Stimulator

AHK-Cu penetrates scalp delivering copper directly to dermal papilla cells. Activates proliferation pathways, elevates Bcl-2/Bax ratio (anti-apoptotic), increases VEGF for blood flow, reduces TGF-β1, and promotes SOD production for oxidative stress reduction.

Half-life: Not established Typical dose: 0.5-1% topical solution/serum skin, healing
tgf betavegf
View full profile

Ipamorelin

Growth Hormone Secretagogue | Selective GHRP

Binds selectively to ghrelin receptors in pituitary gland, stimulating natural GH release with direct systemic delivery via injection, consistent GH pulse stimulation, no significant cortisol or prolactin elevation, and minimal hunger response..

Half-life: ~2 hours Typical dose: 200-300 mcg per injection growth hormone, weight loss, sleep
ghrelin receptorprolactin receptor carcinogenic riskinsulin disruptingteratogenic
View full profile

Combined Organ Load

Blood Vessels
low
Skin
low
Brain
low
GI Tract
low
Pituitary
low

Frequently Asked Questions

Can I take AHK-Cu with Ipamorelin?

Yes, AHK-Cu and Ipamorelin can generally be taken together. AHK-Cu and Ipamorelin work through complementary pathways. Growth hormone signaling supports tissue repair processes. A well-established combination in recovery protocols.

Is AHK-Cu and Ipamorelin safe together?

Based on pharmacological analysis, this combination is considered synergistic. No critical safety flags identified for this pair.

What are the interactions between AHK-Cu and Ipamorelin?

AHK-Cu and Ipamorelin work through complementary pathways. Growth hormone signaling supports tissue repair processes. A well-established combination in recovery protocols. This assessment has 47% confidence and is inferred from pharmacological mechanism analysis.

How should I time AHK-Cu and Ipamorelin?

AHK-Cu has a half-life of Not established and Ipamorelin has a half-life of ~2 hours. No specific timing requirements identified for this combination, but separating administration can help monitor individual effects.

Check this pair in the full Interaction Checker Full comparison: AHK-Cu vs Ipamorelin

This interaction analysis is compiled from research literature and pharmacological mechanism data. This assessment is inferred from known mechanisms and may not reflect all real-world outcomes. Always consult a healthcare professional before combining compounds.